Keynote-177: Phase Iii Randomized Study Of Pembrolizumab Versus Chemotherapy For Microsatellite Instability-High Advanced Colorectal Cancer
JOURNAL OF CLINICAL ONCOLOGY（2021）
摘要
6Background: KEYNOTE-177 (NCT02563002) evaluated the antitumor activity of pembrolizumab (pembro) vs chemotherapy ± bevacizumab or cetuximab (chemo) as first-line therapy for patients with microsat...
更多查看译文
关键词
colorectal cancer,pembrolizumab,chemotherapy,instability-high
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要